Impact of numerical variation in FMS-like tyrosine kinase receptor 3 internal tandem duplications on clinical outcome in normal karyotype acute myelogenous leukemia

Gautam Borthakur, Hagop Kantarjian, Keyur P. Patel, Farhad Ravandi, Wei Qiao, Stefan Faderl, Tapan Kadia, Raja Luthra, Sherry Pierce, Jorge E. Cortes

Research output: Contribution to journalArticle

8 Scopus citations

Abstract

BACKGROUND: The impact of single versus multiple fms-like tyrosine kinase receptor 3 internal tandem duplication (FLT3-ITD) mutations on the clinical outcome of patients with acute myelogenous leukemia has not been well studied, and particularly has not been investigated while simultaneously accounting for the quantitative mutation burden. METHODS: The authors conducted a multivariate analysis of overall survival, event-free survival, and complete remission duration, including numeric variation (single vs multiple) and quantitative mutant burden of FLT3-ITD as variables among other clinically relevant factors. RESULTS: An analysis of a cohort of 1043 patients with AML demonstrated that, among patients with normal-karyotype acute myelogenous leukemia and FLT3-ITD mutation, overall survival and event-free survival were not affected by the number of FLT3-ITD mutations, but complete remission duration was significantly longer in patients who had multiple FLT3-ITD mutations (median, 86 weeks vs 34 weeks; P =.03). CONCLUSIONS: The current results indicated that time-to-event analyses of patients with normal-karyotype acute myelogenous leukemia and FLT3-ITD mutation should take into account the number of mutations and the mutant burden, among other factors.

Original languageEnglish (US)
Pages (from-to)5819-5822
Number of pages4
JournalCancer
Volume118
Issue number23
DOIs
StatePublished - Dec 1 2012

Keywords

  • fms-like tyrosine kinase receptor
  • internal tandem duplication mutation
  • internal tandem duplications
  • normal karyotype acute myelogenous leukemia
  • relapse risk

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Impact of numerical variation in FMS-like tyrosine kinase receptor 3 internal tandem duplications on clinical outcome in normal karyotype acute myelogenous leukemia'. Together they form a unique fingerprint.

  • Cite this